“Tilray CEO Brendan Kennedy told CNBC he met the Smith & Sinclair team about a year and a half ago. He said he “loved” the company’s marketing and product innovation teams, especially the possibilities for CBD-infused edibles.“
I've thought of a Tilray acquisition yet concern that big corporate upon acquisition of CV Sciences would then chip away at stalwart core integrity of CV Sciences and its products.